DE60130464D1 - Pre-adipose zelllinien - Google Patents

Pre-adipose zelllinien

Info

Publication number
DE60130464D1
DE60130464D1 DE60130464T DE60130464T DE60130464D1 DE 60130464 D1 DE60130464 D1 DE 60130464D1 DE 60130464 T DE60130464 T DE 60130464T DE 60130464 T DE60130464 T DE 60130464T DE 60130464 D1 DE60130464 D1 DE 60130464D1
Authority
DE
Germany
Prior art keywords
immortalized
cell lines
cells
adipose
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60130464T
Other languages
English (en)
Other versions
DE60130464T2 (de
Inventor
Christian Darimont
Katherine Mace
Andrea Pfeifer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of DE60130464D1 publication Critical patent/DE60130464D1/de
Application granted granted Critical
Publication of DE60130464T2 publication Critical patent/DE60130464T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60130464T 2000-07-18 2001-07-13 Pre-adipose zelllinien Expired - Fee Related DE60130464T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00115489 2000-07-18
EP00115489 2000-07-18
PCT/EP2001/008165 WO2002006450A1 (en) 2000-07-18 2001-07-13 Pre-adipose cell lines

Publications (2)

Publication Number Publication Date
DE60130464D1 true DE60130464D1 (de) 2007-10-25
DE60130464T2 DE60130464T2 (de) 2008-06-12

Family

ID=8169292

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60130464T Expired - Fee Related DE60130464T2 (de) 2000-07-18 2001-07-13 Pre-adipose zelllinien

Country Status (8)

Country Link
US (1) US7294509B2 (de)
EP (1) EP1303589B1 (de)
JP (1) JP2004504024A (de)
CN (1) CN100595274C (de)
AT (1) ATE373082T1 (de)
AU (1) AU2001277539A1 (de)
DE (1) DE60130464T2 (de)
WO (1) WO2002006450A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050136039A1 (en) * 2002-03-22 2005-06-23 Joslin Diabetes Center, Inc. Adipocytes and uses thereof
WO2003082006A2 (en) * 2002-03-22 2003-10-09 Joslin Diabetes Center, Inc. Methods and compositions for preventing obesity and obesity related disorders
WO2003106663A1 (ja) 2002-06-18 2003-12-24 エーザイ株式会社 遺伝子治療用初代培養脂肪細胞
WO2008103807A2 (en) * 2007-02-21 2008-08-28 Cedars-Sinai Medical Center Methods of producing preadipocytes and increasing the proliferation of adult adipose stem/progenitor cells
CN101259266B (zh) * 2008-04-14 2010-04-14 山东大学 一种前脂肪细胞异种疫苗及其制备方法和用途
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
CN102140437A (zh) * 2011-01-07 2011-08-03 西北农林科技大学 一种猪成熟脂肪细胞快速去分化为前体脂肪细胞的培养方法
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
KR101422559B1 (ko) * 2012-03-09 2014-07-24 창원대학교 산학협력단 지방유래 줄기세포 배양액, 이의 제조방법, 및 이를 포함하는 발모촉진용 조성물
CN102876717B (zh) * 2012-10-29 2014-06-11 东北农业大学 一种建立鸡永生化前脂肪细胞的方法
WO2014172561A1 (en) 2013-04-19 2014-10-23 Biorestorative Therapies, Inc. Human brown adipose derived stem cells and uses
EP3027235A1 (de) 2013-07-30 2016-06-08 Musculoskeletal Transplant Foundation Aus einem azellulären weichgewebe gewonnene matrizen und verfahren zur herstellung davon
PL3227433T3 (pl) * 2014-12-04 2019-01-31 Intervet International B.V. Unieśmiertelnione fibroblasty zarodków kurzych
CA3177726A1 (en) 2015-05-21 2016-11-24 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
US11518982B2 (en) 2015-12-01 2022-12-06 Adiposeeds, Inc. Method for manufacturing mesenchymal cell line derived from vertebrate animal adipose tissue
US20190144831A1 (en) * 2015-12-11 2019-05-16 Intervet Inc. Immortalised chicken embryonic epithelial kidney cells
CN110064443B (zh) * 2018-01-24 2021-07-30 思纳福(北京)医疗科技有限公司 微液滴平铺方法
EP3739323A4 (de) 2018-01-24 2021-03-17 Sniper (Beijing) Medical Technologies Co., Ltd Mikrotropfenbehälter, verfahren zur herstellung eines mikrotropfenbehälters, mikrotropfenausbreitungsverfahren, mikrotropfenbildungskit, temperatursteuervorrichtung, ölphasenzusammensetzung zur mikrotropfenbildung und behandlungsverfahren dafür
EP3738671A4 (de) 2018-01-24 2021-03-24 Sniper (Beijing) Medical Technologies Co., Ltd Bewegungssteuerungsmechanismus, flüssigkeitsausstossende pipettenspitze, mikrotröpfchengenerator, flüssigkeitsantriebsmechanismus und flüssigkeitssteuerungsverfahren, mikrotropfenerzeugungsverfahren und oberflächenbehandlungsverfahren für eine flüssigkeitsausstossende pipettenspitze

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830682A (en) * 1994-09-09 1998-11-03 Zymogenetics Preparation of immortalized cells
FR2733513B1 (fr) * 1995-04-25 1997-07-18 Centre Nat Rech Scient Lignees immortalisees de cellules issues du tissu adipeux humain, leur procede de preparation et leurs applications
US5827740A (en) * 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
JP5055611B2 (ja) * 1998-09-09 2012-10-24 学校法人日本大学 前駆脂肪細胞株
WO2000024866A2 (fr) * 1998-10-26 2000-05-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Lignee cellulaire multipotente du stroma medullaire humain, et ses utilisations

Also Published As

Publication number Publication date
US20030175957A1 (en) 2003-09-18
WO2002006450A1 (en) 2002-01-24
EP1303589B1 (de) 2007-09-12
US7294509B2 (en) 2007-11-13
CN100595274C (zh) 2010-03-24
CN1458973A (zh) 2003-11-26
JP2004504024A (ja) 2004-02-12
ATE373082T1 (de) 2007-09-15
EP1303589A1 (de) 2003-04-23
DE60130464T2 (de) 2008-06-12
AU2001277539A1 (en) 2002-01-30

Similar Documents

Publication Publication Date Title
ATE373082T1 (de) Pre-adipose zelllinien
ATE312635T1 (de) Ventilanordnung
DK1455603T3 (da) Stimulering af in vivo produktion af proteiner med en formulering, der omfatter leucin
BRPI0413241A (pt) composições de adoçante de mesa de monatina e métodos de fazer as mesmas
DE602004030823D1 (de) Verfahren und system zur herstellung von stammzellen aus fettgewebe
EP1670450B8 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE60330781D1 (de) Anwendung von lactobacillus zur herstellung von exopolysacchariden in nahrungsmittel und pharmazeutische zusammensetzungen
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
DE69931907D1 (de) Zusammensetzungen aus hagebutten als anti-entzündliches natürliches arzneimittel zur erleichterung/verringerung von symptomen, die mit entzündungen und arthritis zusammenhängen
TW200719908A (en) Dermatologic use of milk proteins
ATE263571T1 (de) Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen
UA88165C2 (en) Use of trisubstituted benzopyranones
WO2014191056A1 (en) Combination of active agents for treating skin aging
WO2004054558A3 (en) Reduction of breast density with 4-hydroxy tamoxifen
ID27818A (id) Metode untuk menyediakan glutamin
TR200202488T2 (tr) Titanyum içeren yüksek işlevli su ve suyu üretmek için cihaz ve yöntem
EP1623718A4 (de) Mittel zur förderung der hautkollagenproduktion
ES2168845T3 (es) Composicion cosmetica que contiene un componente activo capaz de estimular "in vivo" la produccion de interleuquina 6 (il-6) por los queratinocitos humanos.
TR200200278T2 (tr) Kalsilitik bileşimler
TW200518778A (en) Shampoo composition
MX2019013825A (es) Metodos para producir productos alimenticios basados en plumas.
DE602005010256D1 (de) Produkt pflanzlichen ursprungs, das proanthocyane enthält, sowie verfahren zu seiner herstellung
BRPI0417692A (pt) uso de uma composição, método de redução dos efeitos do estresse mediado psicologicamente na pele de um ser humano ou animal, composição, suplemento nutritivo, composição cosmética, e, método para identificar um composto capaz de reduzir os efeitos e método de produção de uma composição para a redução dos efeitos, do estresse mediado psicologicamente sobre a pele de um ser humano ou animal
FR2893504B1 (fr) Procede d'obtention d'un principe actif exhausteur de la resistance mecanique cutanee, principe actif et compositions
WO2004075821A3 (fr) Utilisation cosmetique d'inositol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee